פודקאסטים

Syqe®’s 2023 study evaluated sex differences in effectiveness, safety, and pharmacokinetics of medical cannabis treatment delivered via the metered-dose SyqeAir Inhaler under real-world conditions. Listen to the podcast.

Syqe®’s 2022 PAIN Reports study examined the long-term effectiveness and safety of medical cannabis treatment delivered via the metered-dose SyqeAir Inhaler under real-world conditions. Listen to the podcast.

Syqe®'s third study (2020) evaluated the SyqeAir Inhaler as a solution for safe, consistent, and low-dose medical cannabis treatment in patients with chronic neuropathic pain. Listen to the podcast>>

Syqe®'s second study examined the use of the SyqeAir Inhaler for medical cannabis administration in hospitals to allow patients to maintain their treatment regimen also during hospitilizations. Listen to the podcast>>

Syqe®'s first study examined whether metered and low doses of Δ9-THC allow for dose-dependent pain reduction of chronic neuropathic pain without significant adverse events. Listen to the podcast>>